Back to News
Market Impact: 0.6

China’s cut-rate DRAM tests Samsung, SK in HBM4 race

HPQDELL
Technology & InnovationAntitrust & CompetitionTrade Policy & Supply ChainEmerging MarketsArtificial IntelligenceCorporate Guidance & OutlookCompany Fundamentals
China’s cut-rate DRAM tests Samsung, SK in HBM4 race

China’s CXMT is undercutting global DRAM prices by offering legacy DDR4 chips at roughly half prevailing market rates, even as PC DRAM DDR4 8Gb contract prices rose to $11.50 at end-January (up 23.7% month-on-month and ~8x year-on-year from $1.35). The pricing push has prompted HP, Dell and Taiwanese OEMs to test or seek cooperation, and is being used to build scale while CXMT converts ~60,000 wafers/month (≈20% of output) at its Shanghai plant to HBM3 with equipment install due H2 and mass production next year. YMTC gained a 10% share of global NAND last year and is building a third Wuhan fab (half capacity for DRAM); the shift risks eroding Samsung and SK hynix’s legacy DRAM revenues — more than half of both firms’ DRAM capacity is in general-purpose products — potentially pressuring incumbents’ margins even if they retain HBM4 leadership.

Analysis

Market structure: Aggressive CXMT pricing (reported ~50% of prevailing DDR4 rates) is a deliberate volume play that directly benefits Chinese suppliers (CXMT/YMTC) and OEMs with tight component cost structures (HPQ, DELL, Acer, Asus). Korean incumbents (Samsung, SK hynix) are exposed because >50% of their DRAM capacity targets legacy/general-purpose products; sustained price undercutting would compress gross margins by mid- to high-single-digit percentage points over 2–4 quarters if legacy ASPs fall 20–40%. Risk assessment: Two primary tail risks exist — (1) US/EU export controls intensify within 3–12 months, stalling Chinese moves and causing sharp tightness that benefits Samsung/SK (upside shock), and (2) rapid Chinese tech improvement plus state subsidies yields faster-than-expected migration into HBM-class chips over 12–36 months (downside for Koreans). Hidden dependencies include OEM qualification cycles (weeks–months), state subsidy timelines, and equipment access (EUV/advanced nodes); catalysts to watch are HP/Dell test results (next 30–90 days) and CXMT Shanghai ramp milestones (H2 this year). Trade implications: Short-to-medium term (weeks–6 months) favors selective longs in OEMs that benefit from lower DRAM input costs (HPQ, DELL) and tactical shorts or hedges on Samsung (005930.KS/SSNLF) and SK hynix (000660.KS) to capture margin erosion. Use options to cap risk: buy 9–12 month 12–18% OTM puts on Korean DRAM names and sell covered calls on HPQ/DELL to monetize theta if testing confirms supply wins. Contrarian angles: The market may under-price an outcomes bifurcation — either Chinese legacy oversupply forces DRAM commoditization (multi-quarter pain for Korean equities) or export controls/quality failures lead to a sharp rebound in ASPs; that uncertainty creates mispricings amenable to pairs and option structures. Historical DRAM cycles show price turnarounds can be violent within 1–3 quarters, so favor size-controlled, event-driven trades with explicit stop-losses and catalyst-based add rules.